By Stat News |
December 03, 2019
Two Senate Democrats are challenging Medicare’s top official to investigate how health care tools based on artificial intelligence may reflect the flaws and biases of the people who develop them — and perpetuate racial biases.
Recent research on Paxlovid shows there is "solid data on its effectiveness," a co-author of the study told HealthLeaders.
One of the most important elements of a company’s success is also one of the least tangible —culture.